NCT00841204 2017-12-26
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
5 trialsNCT00335504 2017-02-15
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT01856322 2015-10-23
Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00118365 2015-01-22
Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps
National Cancer Institute (NCI)
Phase 3 Completed
NCT00368927 2014-05-23
Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
National Cancer Institute (NCI)
Phase 2 Completed